A Randomised, Double-Blind, Placebo-Controlled, 3-Period Cross-Over Study to Evaluate the Effect of Two Doses of GSK2190915 on the Allergen-Induced Early Asthmatic Response in Subjects With Mild Asthma.
Phase of Trial: Phase II
Latest Information Update: 17 Oct 2016
At a glance
- Drugs Fiboflapon (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 08 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Aug 2009 Actual patient number (17) added as reported by ClinicalTrials.gov.
- 08 Aug 2009 Actual end date (1 Jul 2009) added as reported by ClinicalTrials.gov.